We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Stress Biomarker Measurement Method Uses UV Range

By LabMedica International staff writers
Posted on 04 Jun 2019
A recent paper described a novel label-free method for quantitative detection of human performance “stress” biomarkers in different body fluids that is based on optical absorbance of biomarkers in the ultraviolet (UV) range of the spectrum.

The concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids (blood, sweat, urine, and saliva) predict the physical and mental state of the individual. More...
In the current study, investigators at the University of Cincinnati (OH, USA) focused on the stress biomarkers cortisol, serotonin, dopamine, norepinephrine, and neuropeptide Y.

The investigators characterized the UV properties of individual and multiple biomarkers in various biological fluids using a microfluidic/optoelectronic platform for biomarker detection in the 190-400 nm range.

For this study the prime focus was cortisol evaluation. The current limit of detection of cortisol in sweat is approximately 200 nanograms per milliliter, which is in the normal range. UV measurement revealed that plasma samples containing both serotonin and cortisol resulted in readily detectable absorption peaks at 203 (serotonin) and 247 (cortisol) nanometers, confirming the feasibility of simultaneous detection of multiple biomarkers in biological fluid samples. UV spectroscopy performed on various stress biomarkers showed a similar increasing absorption trend with concentration.

The investigators reported that the detection mechanism was label free, applicable to a variety of biomarker types, and able to detect multiple biomarkers simultaneously in various biofluids. A microfluidic flow cell was fabricated on a polymer substrate to enable point-of-care UV measurement of target biomarkers. The overall sensor combined sample dispensing and fluid transport to the detection location with optical absorption measurements with a UV light emitting diode (LED) and photodiode.

"I wanted something that is simple and easy to interpret," said senior author Dr. Andrew Steckl, professor of electrical engineering at the University of Cincinnati. "This may not give you all the information, but it tells you whether you need a professional who can take over. These stress biomarkers are found in all of these fluids, albeit in different quantities. It measures not just one biomarker but multiple biomarkers. And it can be applied to different bodily fluids. That is what is unique."

"You are not going to replace a full-panel laboratory blood test. That is not the intent," said Dr. Steckl. "But if you are able to do the test at home because you are not feeling well and want to know where you stand, this will tell whether your condition has changed a little or a lot."

The UV test for stress biomarkers was described in the May 24, 2019, issue of the journal American Chemical Society Sensors.

Related Links:
University of Cincinnati


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.